Clinical Trial Update: Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT) [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial investigating nanocurcumin for prostate cancer patients undergoing radiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Nanocurcumin (curcumin nanoparticle formulation)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN